Gentamicin

From Citizendium, the Citizens' Compendium
Jump to: navigation, search
This article is a stub and thus not approved.
Main Article
Talk
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and not meant to be cited; by editing it you can help to improve it towards a future approved, citable version. These unapproved articles are subject to a disclaimer.
(CC) Image: David E. Volk
Gentamicin.

Gentamicin is a broad spectrum, aminoglycoside antibiotic obtained from Micromonospora purpurea and related species used to treat serious infections of Pseudomonas aeruginosa, Proteus species, Escherichia coli, Klebsiella-Enterobactor-Serratia and Staphylococcus. It inhibits bacterial growth by binding to the 30S ribosomal subunit, causing incorrect reading of t-RNA and stopping protein synthesis. Aminoglycosides, such as gentamicin, are mostly used against gram-negative aerobic bacteria (acinetobacter, enterobacter and pseudomonas), but they can be used against some mycobacteria, including tuberculosis-causing bacteria. Gram-positive bacteria can be treated with aminoglycosides, but better treatment options exist. Anaerobic bacteria, fungi and viruses cannot be treated with gentamicin or other aminoglycosides. In treating streptococcal infections, the combination therapy of gentamicin with penicillin-based antibiotics have been used in treating endocarditis.

Dosage

The Prins nomogram uses simplified once daily dosing with the dose adjusted for renal function.[1] Depending on the estimated creatinine clearance (CC) (Online calculator), the daily intravenous dose is:

  • CC more than 80 ml/min - 4 mg/kg
  • CC between 50 and 80 ml/min - 3.25 mg/kg
  • CC between 30 and 50 ml/min - 2.5 mg/kg
  • CC below 30 ml/min - 2 mg/kg

The older Hull and Sarubbi nomogram uses a loading dose followed by smaller maintenance doses depending on renal function.[2]


Mechanism of action

Aminoglycosides irreversibly bind to specific 30S-subunit proteins and 16S rRNA. Specifically, gentamicin binds to four nucleotides of the 16S rRNA and one amino acid in protein S12. This interferes with decoding near nucleotide 1400 in 16S rRNA of the 30S subunit, interfering with the formation of an initiation complex, causing misreading of mRNA so that incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes.

Brand names

  • Alcomicin®
  • Apogen®
  • Bristagen®
  • G-Mycin®
  • G-Myticin®
  • Garamycin®
  • Garamycin Otic Solution®
  • Genoptic Liquifilm®
  • Genoptic S.O.P.®
  • Gentacidin®
  • Gentafair®
  • Gentak®
  • Gentamar®
  • Gentamcin Sulfate®
  • Jenamicin®
  • Ocu-Mycin®
  • Spectro-Genta®
  • U-gencin®

External links

The most up-to-date information about Gentamicin and other drugs can be found at the following sites.

References

  1. Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P (1996). "Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy". Antimicrob. Agents Chemother. 40 (11): 2494–9. PMID 8913452[e] Full text at PubMed Central
  2. Hull JH, Sarubbi FA (1976). "Gentamicin serum concentrations: pharmacokinetic predictions". Ann. Intern. Med. 85 (2): 183–9. PMID 942138[e] online